Bristol-Myers Squibb CompanyBMYNYSE
LOADING
|||
BMYOperating Expenses Over Time
Above historical average, modest growth trend.
Left:
|||
Expenses from normal business operations (SG&A, R&D, etc.)
Latest
$17.77B
↑ 32% above average
Average (9y)
$13.47B
Historical baseline
Range
High:$17.77B
Low:$8.87B
CAGR
+8.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $17.77B | +5.3% |
| 2023 | $16.89B | -1.9% |
| 2022 | $17.22B | -0.0% |
| 2021 | $17.22B | +0.1% |
| 2020 | $17.21B | +59.2% |
| 2019 | $10.81B | +11.7% |
| 2018 | $9.68B | -0.4% |
| 2017 | $9.72B | +4.3% |
| 2016 | $9.32B | +5.1% |
| 2015 | $8.87B | - |